JERSEY CITY, N.J. - Monday, 18. December 2023
Organon becomes the sole distributor and promoter of Emgality® (galcanezumab) and RAYVOW™ (lasmiditan) in Europe, building on strong commercial expertise in central nervous system disorders
Expands Organon’s European product portfolio in a con…